T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells. 2014

Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
Institute for Biomedical Aging Research, Immunology Division, University of Innsbruck, 6020 Innsbruck, Austria.

A key feature of the aged human immune system is the accumulation of highly differentiated CD8(+)CD28(-) T cells, a phenomenon that negatively influences immune function in the elderly. However, the mechanisms that regulate survival or death of CD8(+)CD28(-) T cells remain incompletely understood. Macroautophagy has been shown to protect cells from unfavorable environmental conditions and extend lifespan of various cells and organisms. In this study, we investigated autophagy in CD8(+)CD28(+) and CD8(+)CD28(-) T cells following T cell receptor (TCR) engagement. We demonstrate that TCR-mediated activation led to a potent induction of autophagy in CD8(+)CD28(+) T cells which was accompanied by an increased activity of the mammalian target of rapamycin complex 1 (mTORC1). This was surprising, as mTORC1 is generally perceived as an inhibitor of autophagy. Inhibition of mTORC1 by rapamycin could still enhance activation-induced autophagy. In contrast, CD8(+)CD28(-) T cells induced autophagy to a significantly lower extent in response to TCR engagement compared to CD8(+)CD28(+) T cells and failed to increase autophagy upon mTORC1 inhibition. In conclusion, we describe for the first time the induction of autophagy in human CD8(+) T cells following TCR engagement and the decreased ability of CD8(+)CD28(-) T cells to induce autophagy, suggesting that they cannot meet the metabolic needs of antigen receptor-mediated activation and are therefore unlikely to survive when confronted by their specific antigens.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076222 Mechanistic Target of Rapamycin Complex 1 An evolutionarily conserved multiprotein complex that functions as a cellular energy sensor and regulator of protein synthesis for cell growth and proliferation. It consists of TOR SERINE-THREONINE KINASES; REGULATORY-ASSOCIATED PROTEIN OF MTOR (RAPTOR); MLST8 PROTEIN; and AKT1 substrate 1 protein. The activity of the complex is regulated by SIROLIMUS; INSULIN; GROWTH FACTORS; PHOSPHATIDIC ACIDS; some amino acids or amino acid derivatives, and OXIDATIVE STRESS. TOR Complex 1,TORC1,Target of Rapamycin Complex 1,mTORC1,mTORC1 Complex,Complex, mTORC1
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
February 2009, Human immunology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
January 1994, European journal of immunology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
July 2008, AIDS research and human retroviruses,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
April 2020, Cellular microbiology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
April 2009, Biogerontology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
August 2018, Cellular & molecular immunology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
March 2001, Cancer research,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
December 2003, The Journal of investigative dermatology,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
June 2014, Science signaling,
Christoph R Arnold, and Theresa Pritz, and Stefan Brunner, and Carina Knabb, and Willi Salvenmoser, and Birgit Holzwarth, and Kathrin Thedieck, and Beatrix Grubeck-Loebenstein
March 1997, Clinical and experimental immunology,
Copied contents to your clipboard!